Mallinckrodt plc
Mallinckrodt plc MNK Peers
See (MNK) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MNK | $0.34 | -14.97% | 4.5M | -0.44 | -$0.78 | N/A |
| ZTS | $167.13 | +1.05% | 74.4B | 30.01 | $5.57 | +1.12% |
| HLN | $11.33 | +0.67% | 51.1B | 26.34 | $0.43 | +1.48% |
| TAK | $14.79 | +1.37% | 46.5B | 64.30 | $0.23 | +3.98% |
| TEVA | $17.51 | -3.55% | 20.1B | -15.22 | -$1.15 | N/A |
| ITCI | $131.87 | N/A | 14B | -180.64 | -$0.73 | N/A |
| RDY | $14.75 | +1.27% | 12.3B | 18.43 | $0.80 | +0.65% |
| NBIX | $123.66 | +0.51% | 12.2B | 41.78 | $2.96 | N/A |
| CTLT | $63.48 | N/A | 11.5B | -27.84 | -$2.28 | N/A |
| VTRS | $8.83 | +2.79% | 10.4B | -2.78 | -$3.18 | +5.45% |
Stock Comparison
MNK vs ZTS Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ZTS has a market cap of 74.4B. Regarding current trading prices, MNK is priced at $0.34, while ZTS trades at $167.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ZTS's P/E ratio is 30.01. In terms of profitability, MNK's ROE is +1.26%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, MNK is more volatile compared to ZTS. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs HLN Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, HLN has a market cap of 51.1B. Regarding current trading prices, MNK is priced at $0.34, while HLN trades at $11.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas HLN's P/E ratio is 26.34. In terms of profitability, MNK's ROE is +1.26%, compared to HLN's ROE of +0.09%. Regarding short-term risk, MNK is more volatile compared to HLN. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs TAK Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, TAK has a market cap of 46.5B. Regarding current trading prices, MNK is priced at $0.34, while TAK trades at $14.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas TAK's P/E ratio is 64.30. In terms of profitability, MNK's ROE is +1.26%, compared to TAK's ROE of +0.04%. Regarding short-term risk, MNK is more volatile compared to TAK. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs TEVA Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, TEVA has a market cap of 20.1B. Regarding current trading prices, MNK is priced at $0.34, while TEVA trades at $17.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas TEVA's P/E ratio is -15.22. In terms of profitability, MNK's ROE is +1.26%, compared to TEVA's ROE of -0.21%. Regarding short-term risk, MNK is more volatile compared to TEVA. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs ITCI Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, MNK is priced at $0.34, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ITCI's P/E ratio is -180.64. In terms of profitability, MNK's ROE is +1.26%, compared to ITCI's ROE of -0.07%. Regarding short-term risk, MNK is more volatile compared to ITCI. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs RDY Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, RDY has a market cap of 12.3B. Regarding current trading prices, MNK is priced at $0.34, while RDY trades at $14.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas RDY's P/E ratio is 18.43. In terms of profitability, MNK's ROE is +1.26%, compared to RDY's ROE of +0.18%. Regarding short-term risk, MNK is more volatile compared to RDY. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs NBIX Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, NBIX has a market cap of 12.2B. Regarding current trading prices, MNK is priced at $0.34, while NBIX trades at $123.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas NBIX's P/E ratio is 41.78. In terms of profitability, MNK's ROE is +1.26%, compared to NBIX's ROE of +0.12%. Regarding short-term risk, MNK is more volatile compared to NBIX. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs CTLT Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, MNK is priced at $0.34, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas CTLT's P/E ratio is -27.84. In terms of profitability, MNK's ROE is +1.26%, compared to CTLT's ROE of -0.11%. Regarding short-term risk, MNK is more volatile compared to CTLT. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs VTRS Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, VTRS has a market cap of 10.4B. Regarding current trading prices, MNK is priced at $0.34, while VTRS trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas VTRS's P/E ratio is -2.78. In terms of profitability, MNK's ROE is +1.26%, compared to VTRS's ROE of -0.21%. Regarding short-term risk, MNK is more volatile compared to VTRS. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs RGC Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, RGC has a market cap of 9.8B. Regarding current trading prices, MNK is priced at $0.34, while RGC trades at $755.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas RGC's P/E ratio is -2435.48. In terms of profitability, MNK's ROE is +1.26%, compared to RGC's ROE of -0.25%. Regarding short-term risk, MNK is less volatile compared to RGC. This indicates potentially lower risk in terms of short-term price fluctuations for MNK.
MNK vs ELAN Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ELAN has a market cap of 6.7B. Regarding current trading prices, MNK is priced at $0.34, while ELAN trades at $13.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ELAN's P/E ratio is 18.03. In terms of profitability, MNK's ROE is +1.26%, compared to ELAN's ROE of +0.06%. Regarding short-term risk, MNK is more volatile compared to ELAN. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs LNTH Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, LNTH has a market cap of 5.2B. Regarding current trading prices, MNK is priced at $0.34, while LNTH trades at $75.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas LNTH's P/E ratio is 21.52. In terms of profitability, MNK's ROE is +1.26%, compared to LNTH's ROE of +0.23%. Regarding short-term risk, MNK is more volatile compared to LNTH. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs PRGO Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, PRGO has a market cap of 3.7B. Regarding current trading prices, MNK is priced at $0.34, while PRGO trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas PRGO's P/E ratio is -22.61. In terms of profitability, MNK's ROE is +1.26%, compared to PRGO's ROE of -0.04%. Regarding short-term risk, MNK is more volatile compared to PRGO. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs AMRX Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, AMRX has a market cap of 3.4B. Regarding current trading prices, MNK is priced at $0.34, while AMRX trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas AMRX's P/E ratio is -182.50. In terms of profitability, MNK's ROE is +1.26%, compared to AMRX's ROE of -0.07%. Regarding short-term risk, MNK is more volatile compared to AMRX. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs ALVO Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ALVO has a market cap of 3.4B. Regarding current trading prices, MNK is priced at $0.34, while ALVO trades at $11.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ALVO's P/E ratio is 30.19. In terms of profitability, MNK's ROE is +1.26%, compared to ALVO's ROE of -0.23%. Regarding short-term risk, MNK is more volatile compared to ALVO. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs ALVOW Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ALVOW has a market cap of 3.3B. Regarding current trading prices, MNK is priced at $0.34, while ALVOW trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ALVOW's P/E ratio is N/A. In terms of profitability, MNK's ROE is +1.26%, compared to ALVOW's ROE of -0.23%. Regarding short-term risk, MNK is more volatile compared to ALVOW. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs BGM Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, BGM has a market cap of 3.2B. Regarding current trading prices, MNK is priced at $0.34, while BGM trades at $13.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas BGM's P/E ratio is -69.65. In terms of profitability, MNK's ROE is +1.26%, compared to BGM's ROE of -0.03%. Regarding short-term risk, MNK is more volatile compared to BGM. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs HCM Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, HCM has a market cap of 2.5B. Regarding current trading prices, MNK is priced at $0.34, while HCM trades at $13.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas HCM's P/E ratio is 69.30. In terms of profitability, MNK's ROE is +1.26%, compared to HCM's ROE of +0.05%. Regarding short-term risk, MNK is more volatile compared to HCM. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs DCPH Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, MNK is priced at $0.34, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas DCPH's P/E ratio is -11.58. In terms of profitability, MNK's ROE is +1.26%, compared to DCPH's ROE of -0.28%. Regarding short-term risk, MNK is more volatile compared to DCPH. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs EMBCV Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, MNK is priced at $0.34, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas EMBCV's P/E ratio is N/A. In terms of profitability, MNK's ROE is +1.26%, compared to EMBCV's ROE of -0.07%. Regarding short-term risk, MNK is more volatile compared to EMBCV. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs SUPN Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, SUPN has a market cap of 1.8B. Regarding current trading prices, MNK is priced at $0.34, while SUPN trades at $31.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas SUPN's P/E ratio is 28.54. In terms of profitability, MNK's ROE is +1.26%, compared to SUPN's ROE of +0.06%. Regarding short-term risk, MNK is more volatile compared to SUPN. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs BHC Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, BHC has a market cap of 1.7B. Regarding current trading prices, MNK is priced at $0.34, while BHC trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas BHC's P/E ratio is -38.33. In terms of profitability, MNK's ROE is +1.26%, compared to BHC's ROE of +0.05%. Regarding short-term risk, MNK is more volatile compared to BHC. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs TARO Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, MNK is priced at $0.34, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas TARO's P/E ratio is 30.05. In terms of profitability, MNK's ROE is +1.26%, compared to TARO's ROE of +0.03%. Regarding short-term risk, MNK is more volatile compared to TARO. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs INDV Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, INDV has a market cap of 1.5B. Regarding current trading prices, MNK is priced at $0.34, while INDV trades at $12.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas INDV's P/E ratio is -248.20. In terms of profitability, MNK's ROE is +1.26%, compared to INDV's ROE of -0.01%. Regarding short-term risk, MNK is more volatile compared to INDV. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs EVO Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, EVO has a market cap of 1.3B. Regarding current trading prices, MNK is priced at $0.34, while EVO trades at $3.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas EVO's P/E ratio is -5.64. In terms of profitability, MNK's ROE is +1.26%, compared to EVO's ROE of -0.22%. Regarding short-term risk, MNK is more volatile compared to EVO. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs ANIP Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ANIP has a market cap of 1.3B. Regarding current trading prices, MNK is priced at $0.34, while ANIP trades at $58.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ANIP's P/E ratio is -49.42. In terms of profitability, MNK's ROE is +1.26%, compared to ANIP's ROE of -0.05%. Regarding short-term risk, MNK is more volatile compared to ANIP. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs AMPH Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, AMPH has a market cap of 1.2B. Regarding current trading prices, MNK is priced at $0.34, while AMPH trades at $25.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas AMPH's P/E ratio is 9.29. In terms of profitability, MNK's ROE is +1.26%, compared to AMPH's ROE of +0.19%. Regarding short-term risk, MNK is more volatile compared to AMPH. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs PCRX Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, PCRX has a market cap of 1.2B. Regarding current trading prices, MNK is priced at $0.34, while PCRX trades at $25.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas PCRX's P/E ratio is -11.58. In terms of profitability, MNK's ROE is +1.26%, compared to PCRX's ROE of -0.13%. Regarding short-term risk, MNK is more volatile compared to PCRX. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs DVAX Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, DVAX has a market cap of 1.2B. Regarding current trading prices, MNK is priced at $0.34, while DVAX trades at $9.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas DVAX's P/E ratio is -19.52. In terms of profitability, MNK's ROE is +1.26%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, MNK is more volatile compared to DVAX. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs PAHC Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, PAHC has a market cap of 999.6M. Regarding current trading prices, MNK is priced at $0.34, while PAHC trades at $24.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas PAHC's P/E ratio is 31.62. In terms of profitability, MNK's ROE is +1.26%, compared to PAHC's ROE of +0.12%. Regarding short-term risk, MNK is more volatile compared to PAHC. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs HROW Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, HROW has a market cap of 998.2M. Regarding current trading prices, MNK is priced at $0.34, while HROW trades at $27.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas HROW's P/E ratio is -44.59. In terms of profitability, MNK's ROE is +1.26%, compared to HROW's ROE of -0.36%. Regarding short-term risk, MNK is more volatile compared to HROW. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs COLL Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, COLL has a market cap of 937.9M. Regarding current trading prices, MNK is priced at $0.34, while COLL trades at $29.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas COLL's P/E ratio is 23.92. In terms of profitability, MNK's ROE is +1.26%, compared to COLL's ROE of +0.19%. Regarding short-term risk, MNK is more volatile compared to COLL. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs PETQ Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, MNK is priced at $0.34, while PETQ trades at $30.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas PETQ's P/E ratio is 83.73. In terms of profitability, MNK's ROE is +1.26%, compared to PETQ's ROE of +0.06%. Regarding short-term risk, MNK is more volatile compared to PETQ. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs AVDL Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, AVDL has a market cap of 891.9M. Regarding current trading prices, MNK is priced at $0.34, while AVDL trades at $9.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas AVDL's P/E ratio is -35.46. In terms of profitability, MNK's ROE is +1.26%, compared to AVDL's ROE of -0.36%. Regarding short-term risk, MNK is more volatile compared to AVDL. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs CRON Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, CRON has a market cap of 790.1M. Regarding current trading prices, MNK is priced at $0.34, while CRON trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas CRON's P/E ratio is 14.64. In terms of profitability, MNK's ROE is +1.26%, compared to CRON's ROE of +0.05%. Regarding short-term risk, MNK is more volatile compared to CRON. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs EMBC Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, EMBC has a market cap of 611M. Regarding current trading prices, MNK is priced at $0.34, while EMBC trades at $10.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas EMBC's P/E ratio is 11.75. In terms of profitability, MNK's ROE is +1.26%, compared to EMBC's ROE of -0.07%. Regarding short-term risk, MNK is more volatile compared to EMBC. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs EOLS Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, EOLS has a market cap of 602.2M. Regarding current trading prices, MNK is priced at $0.34, while EOLS trades at $9.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas EOLS's P/E ratio is -10.49. In terms of profitability, MNK's ROE is +1.26%, compared to EOLS's ROE of -9.32%. Regarding short-term risk, MNK is more volatile compared to EOLS. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs BDSI Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, MNK is priced at $0.34, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas BDSI's P/E ratio is 6.82. In terms of profitability, MNK's ROE is +1.26%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, MNK is more volatile compared to BDSI. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs TLRY Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, TLRY has a market cap of 476.5M. Regarding current trading prices, MNK is priced at $0.34, while TLRY trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas TLRY's P/E ratio is -0.42. In terms of profitability, MNK's ROE is +1.26%, compared to TLRY's ROE of -0.29%. Regarding short-term risk, MNK is more volatile compared to TLRY. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs SIGA Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, SIGA has a market cap of 439.7M. Regarding current trading prices, MNK is priced at $0.34, while SIGA trades at $6.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas SIGA's P/E ratio is 9.19. In terms of profitability, MNK's ROE is +1.26%, compared to SIGA's ROE of +0.25%. Regarding short-term risk, MNK is more volatile compared to SIGA. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs KMDA Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, KMDA has a market cap of 395.1M. Regarding current trading prices, MNK is priced at $0.34, while KMDA trades at $6.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas KMDA's P/E ratio is 24.54. In terms of profitability, MNK's ROE is +1.26%, compared to KMDA's ROE of +0.06%. Regarding short-term risk, MNK is more volatile compared to KMDA. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs ZYBT Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ZYBT has a market cap of 387.7M. Regarding current trading prices, MNK is priced at $0.34, while ZYBT trades at $8.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ZYBT's P/E ratio is 136.33. In terms of profitability, MNK's ROE is +1.26%, compared to ZYBT's ROE of +0.11%. Regarding short-term risk, MNK is more volatile compared to ZYBT. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs ORGO Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ORGO has a market cap of 362.2M. Regarding current trading prices, MNK is priced at $0.34, while ORGO trades at $2.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ORGO's P/E ratio is -17.84. In terms of profitability, MNK's ROE is +1.26%, compared to ORGO's ROE of -0.06%. Regarding short-term risk, MNK is more volatile compared to ORGO. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs EBS Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, EBS has a market cap of 351.7M. Regarding current trading prices, MNK is priced at $0.34, while EBS trades at $6.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas EBS's P/E ratio is -2.51. In terms of profitability, MNK's ROE is +1.26%, compared to EBS's ROE of -0.27%. Regarding short-term risk, MNK is more volatile compared to EBS. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs SNDL Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, SNDL has a market cap of 334.5M. Regarding current trading prices, MNK is priced at $0.34, while SNDL trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas SNDL's P/E ratio is -4.33. In terms of profitability, MNK's ROE is +1.26%, compared to SNDL's ROE of -0.09%. Regarding short-term risk, MNK is more volatile compared to SNDL. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs TKNO Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, TKNO has a market cap of 315.8M. Regarding current trading prices, MNK is priced at $0.34, while TKNO trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas TKNO's P/E ratio is -12.85. In terms of profitability, MNK's ROE is +1.26%, compared to TKNO's ROE of -0.28%. Regarding short-term risk, MNK is more volatile compared to TKNO. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs CGC Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, CGC has a market cap of 307.9M. Regarding current trading prices, MNK is priced at $0.34, while CGC trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas CGC's P/E ratio is -0.46. In terms of profitability, MNK's ROE is +1.26%, compared to CGC's ROE of -0.88%. Regarding short-term risk, MNK is more volatile compared to CGC. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs ACB Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ACB has a market cap of 303.2M. Regarding current trading prices, MNK is priced at $0.34, while ACB trades at $5.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ACB's P/E ratio is 27.63. In terms of profitability, MNK's ROE is +1.26%, compared to ACB's ROE of +0.02%. Regarding short-term risk, MNK is more volatile compared to ACB. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs ALIM Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, MNK is priced at $0.34, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ALIM's P/E ratio is 5.28. In terms of profitability, MNK's ROE is +1.26%, compared to ALIM's ROE of -0.32%. Regarding short-term risk, MNK is more volatile compared to ALIM. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs AQST Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, AQST has a market cap of 277.1M. Regarding current trading prices, MNK is priced at $0.34, while AQST trades at $2.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas AQST's P/E ratio is -4.81. In terms of profitability, MNK's ROE is +1.26%, compared to AQST's ROE of +1.07%. Regarding short-term risk, MNK is more volatile compared to AQST. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs LNDC Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, MNK is priced at $0.34, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas LNDC's P/E ratio is -4.04. In terms of profitability, MNK's ROE is +1.26%, compared to LNDC's ROE of +2.28%. Regarding short-term risk, MNK is more volatile compared to LNDC. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs LFCR Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, LFCR has a market cap of 253.6M. Regarding current trading prices, MNK is priced at $0.34, while LFCR trades at $6.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas LFCR's P/E ratio is -4.66. In terms of profitability, MNK's ROE is +1.26%, compared to LFCR's ROE of -2.64%. Regarding short-term risk, MNK is more volatile compared to LFCR. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs TYHT Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, MNK is priced at $0.34, while TYHT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas TYHT's P/E ratio is -1.61. In terms of profitability, MNK's ROE is +1.26%, compared to TYHT's ROE of -1.41%. Regarding short-term risk, MNK is more volatile compared to TYHT. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs DERM Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, DERM has a market cap of 188M. Regarding current trading prices, MNK is priced at $0.34, while DERM trades at $8.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas DERM's P/E ratio is -21.81. In terms of profitability, MNK's ROE is +1.26%, compared to DERM's ROE of -0.52%. Regarding short-term risk, MNK is more volatile compared to DERM. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs OGI Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, OGI has a market cap of 184.8M. Regarding current trading prices, MNK is priced at $0.34, while OGI trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas OGI's P/E ratio is 11.50. In terms of profitability, MNK's ROE is +1.26%, compared to OGI's ROE of +0.05%. Regarding short-term risk, MNK is more volatile compared to OGI. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs REPH Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, MNK is priced at $0.34, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas REPH's P/E ratio is -8.04. In terms of profitability, MNK's ROE is +1.26%, compared to REPH's ROE of -0.15%. Regarding short-term risk, MNK is more volatile compared to REPH. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs ESPR Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ESPR has a market cap of 172.6M. Regarding current trading prices, MNK is priced at $0.34, while ESPR trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ESPR's P/E ratio is -1.02. In terms of profitability, MNK's ROE is +1.26%, compared to ESPR's ROE of +0.40%. Regarding short-term risk, MNK is more volatile compared to ESPR. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs BIOA Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, BIOA has a market cap of 142.7M. Regarding current trading prices, MNK is priced at $0.34, while BIOA trades at $3.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas BIOA's P/E ratio is -2.01. In terms of profitability, MNK's ROE is +1.26%, compared to BIOA's ROE of -0.38%. Regarding short-term risk, MNK is more volatile compared to BIOA. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs THTX Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, THTX has a market cap of 119.5M. Regarding current trading prices, MNK is priced at $0.34, while THTX trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas THTX's P/E ratio is -37.14. In terms of profitability, MNK's ROE is +1.26%, compared to THTX's ROE of +0.16%. Regarding short-term risk, MNK is more volatile compared to THTX. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs SCTL Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, MNK is priced at $0.34, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas SCTL's P/E ratio is -7.86. In terms of profitability, MNK's ROE is +1.26%, compared to SCTL's ROE of -0.15%. Regarding short-term risk, MNK is more volatile compared to SCTL. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs PROC Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, PROC has a market cap of 114M. Regarding current trading prices, MNK is priced at $0.34, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas PROC's P/E ratio is 1.53. In terms of profitability, MNK's ROE is +1.26%, compared to PROC's ROE of -2.22%. Regarding short-term risk, MNK is more volatile compared to PROC. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs CRDL Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, CRDL has a market cap of 103.3M. Regarding current trading prices, MNK is priced at $0.34, while CRDL trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas CRDL's P/E ratio is -3.68. In terms of profitability, MNK's ROE is +1.26%, compared to CRDL's ROE of -2.08%. Regarding short-term risk, MNK is more volatile compared to CRDL. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs IRWD Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, IRWD has a market cap of 103.1M. Regarding current trading prices, MNK is priced at $0.34, while IRWD trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas IRWD's P/E ratio is -3.35. In terms of profitability, MNK's ROE is +1.26%, compared to IRWD's ROE of +0.10%. Regarding short-term risk, MNK is more volatile compared to IRWD. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs OPTN Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, MNK is priced at $0.34, while OPTN trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas OPTN's P/E ratio is -4.42. In terms of profitability, MNK's ROE is +1.26%, compared to OPTN's ROE of +0.64%. Regarding short-term risk, MNK is more volatile compared to OPTN. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs ZOM Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, MNK is priced at $0.34, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ZOM's P/E ratio is -1.62. In terms of profitability, MNK's ROE is +1.26%, compared to ZOM's ROE of -0.55%. Regarding short-term risk, MNK is more volatile compared to ZOM. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs GRVI Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, MNK is priced at $0.34, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas GRVI's P/E ratio is 26.05. In terms of profitability, MNK's ROE is +1.26%, compared to GRVI's ROE of -5.25%. Regarding short-term risk, MNK is more volatile compared to GRVI. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs CPIX Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, CPIX has a market cap of 75.3M. Regarding current trading prices, MNK is priced at $0.34, while CPIX trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas CPIX's P/E ratio is -20.96. In terms of profitability, MNK's ROE is +1.26%, compared to CPIX's ROE of -0.13%. Regarding short-term risk, MNK is more volatile compared to CPIX. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs INCR Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, INCR has a market cap of 74.5M. Regarding current trading prices, MNK is priced at $0.34, while INCR trades at $1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas INCR's P/E ratio is -3.76. In terms of profitability, MNK's ROE is +1.26%, compared to INCR's ROE of -0.07%. Regarding short-term risk, MNK is more volatile compared to INCR. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs ZYNE Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, MNK is priced at $0.34, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, MNK's ROE is +1.26%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, MNK is more volatile compared to ZYNE. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs SSIC Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, MNK is priced at $0.34, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas SSIC's P/E ratio is 11.93. In terms of profitability, MNK's ROE is +1.26%, compared to SSIC's ROE of +0.03%. Regarding short-term risk, MNK is more volatile compared to SSIC. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs ASRT Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ASRT has a market cap of 65M. Regarding current trading prices, MNK is priced at $0.34, while ASRT trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ASRT's P/E ratio is -2.12. In terms of profitability, MNK's ROE is +1.26%, compared to ASRT's ROE of -0.24%. Regarding short-term risk, MNK is more volatile compared to ASRT. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs VLNS Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, MNK is priced at $0.34, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas VLNS's P/E ratio is -1.03. In terms of profitability, MNK's ROE is +1.26%, compared to VLNS's ROE of N/A. Regarding short-term risk, MNK is more volatile compared to VLNS. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs JUPW Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, MNK is priced at $0.34, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas JUPW's P/E ratio is -2.41. In terms of profitability, MNK's ROE is +1.26%, compared to JUPW's ROE of -9.40%. Regarding short-term risk, MNK is more volatile compared to JUPW. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs QLI Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, MNK is priced at $0.34, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas QLI's P/E ratio is -4.92. In terms of profitability, MNK's ROE is +1.26%, compared to QLI's ROE of -0.16%. Regarding short-term risk, MNK is more volatile compared to QLI. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs SXTC Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, SXTC has a market cap of 38M. Regarding current trading prices, MNK is priced at $0.34, while SXTC trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas SXTC's P/E ratio is 0.01. In terms of profitability, MNK's ROE is +1.26%, compared to SXTC's ROE of +0.47%. Regarding short-term risk, MNK is more volatile compared to SXTC. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs QNTM Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, QNTM has a market cap of 36.7M. Regarding current trading prices, MNK is priced at $0.34, while QNTM trades at $12.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas QNTM's P/E ratio is -0.95. In terms of profitability, MNK's ROE is +1.26%, compared to QNTM's ROE of -1.88%. Regarding short-term risk, MNK is more volatile compared to QNTM. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs SCYX Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, SCYX has a market cap of 34.8M. Regarding current trading prices, MNK is priced at $0.34, while SCYX trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas SCYX's P/E ratio is -1.59. In terms of profitability, MNK's ROE is +1.26%, compared to SCYX's ROE of -0.48%. Regarding short-term risk, MNK is more volatile compared to SCYX. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs RMTI Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, RMTI has a market cap of 32.3M. Regarding current trading prices, MNK is priced at $0.34, while RMTI trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas RMTI's P/E ratio is -94.41. In terms of profitability, MNK's ROE is +1.26%, compared to RMTI's ROE of -0.01%. Regarding short-term risk, MNK is more volatile compared to RMTI. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs HEXO Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, MNK is priced at $0.34, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas HEXO's P/E ratio is -0.26. In terms of profitability, MNK's ROE is +1.26%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, MNK is more volatile compared to HEXO. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs KALA Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, KALA has a market cap of 24.8M. Regarding current trading prices, MNK is priced at $0.34, while KALA trades at $3.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas KALA's P/E ratio is -0.52. In terms of profitability, MNK's ROE is +1.26%, compared to KALA's ROE of -3.69%. Regarding short-term risk, MNK is more volatile compared to KALA. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs CYTH Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, MNK is priced at $0.34, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas CYTH's P/E ratio is -0.80. In terms of profitability, MNK's ROE is +1.26%, compared to CYTH's ROE of +7.50%. Regarding short-term risk, MNK is more volatile compared to CYTH. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs EGRX Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, EGRX has a market cap of 23.3M. Regarding current trading prices, MNK is priced at $0.34, while EGRX trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas EGRX's P/E ratio is 2.12. In terms of profitability, MNK's ROE is +1.26%, compared to EGRX's ROE of +0.17%. Regarding short-term risk, MNK is more volatile compared to EGRX. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs TXMD Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, TXMD has a market cap of 17.1M. Regarding current trading prices, MNK is priced at $0.34, while TXMD trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas TXMD's P/E ratio is -7.79. In terms of profitability, MNK's ROE is +1.26%, compared to TXMD's ROE of -0.08%. Regarding short-term risk, MNK is more volatile compared to TXMD. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs DRRX Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, DRRX has a market cap of 16.9M. Regarding current trading prices, MNK is priced at $0.34, while DRRX trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas DRRX's P/E ratio is -1.13. In terms of profitability, MNK's ROE is +1.26%, compared to DRRX's ROE of -0.93%. Regarding short-term risk, MNK is more volatile compared to DRRX. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs IXHL Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, IXHL has a market cap of 16M. Regarding current trading prices, MNK is priced at $0.34, while IXHL trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas IXHL's P/E ratio is -0.18. In terms of profitability, MNK's ROE is +1.26%, compared to IXHL's ROE of -2.03%. Regarding short-term risk, MNK is more volatile compared to IXHL. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs GELS Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, GELS has a market cap of 15.9M. Regarding current trading prices, MNK is priced at $0.34, while GELS trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas GELS's P/E ratio is -7.00. In terms of profitability, MNK's ROE is +1.26%, compared to GELS's ROE of -0.21%. Regarding short-term risk, MNK is more volatile compared to GELS. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs FLGC Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, FLGC has a market cap of 15.5M. Regarding current trading prices, MNK is priced at $0.34, while FLGC trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas FLGC's P/E ratio is -0.71. In terms of profitability, MNK's ROE is +1.26%, compared to FLGC's ROE of -2.55%. Regarding short-term risk, MNK is more volatile compared to FLGC. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs IMCC Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, IMCC has a market cap of 15.4M. Regarding current trading prices, MNK is priced at $0.34, while IMCC trades at $4.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas IMCC's P/E ratio is -3.62. In terms of profitability, MNK's ROE is +1.26%, compared to IMCC's ROE of -1.52%. Regarding short-term risk, MNK is less volatile compared to IMCC. This indicates potentially lower risk in terms of short-term price fluctuations for MNK.
MNK vs PRPH Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, PRPH has a market cap of 15.2M. Regarding current trading prices, MNK is priced at $0.34, while PRPH trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas PRPH's P/E ratio is -0.17. In terms of profitability, MNK's ROE is +1.26%, compared to PRPH's ROE of -1.59%. Regarding short-term risk, MNK is more volatile compared to PRPH. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs SISI Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, SISI has a market cap of 14.6M. Regarding current trading prices, MNK is priced at $0.34, while SISI trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas SISI's P/E ratio is N/A. In terms of profitability, MNK's ROE is +1.26%, compared to SISI's ROE of -1.41%. Regarding short-term risk, MNK is more volatile compared to SISI. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs ACRX Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, MNK is priced at $0.34, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas ACRX's P/E ratio is -0.31. In terms of profitability, MNK's ROE is +1.26%, compared to ACRX's ROE of -2.49%. Regarding short-term risk, MNK is more volatile compared to ACRX. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs COSM Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, COSM has a market cap of 12.7M. Regarding current trading prices, MNK is priced at $0.34, while COSM trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas COSM's P/E ratio is -0.41. In terms of profitability, MNK's ROE is +1.26%, compared to COSM's ROE of -0.51%. Regarding short-term risk, MNK is more volatile compared to COSM. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs AYTU Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, AYTU has a market cap of 11.3M. Regarding current trading prices, MNK is priced at $0.34, while AYTU trades at $1.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas AYTU's P/E ratio is -1.23. In terms of profitability, MNK's ROE is +1.26%, compared to AYTU's ROE of +0.05%. Regarding short-term risk, MNK is more volatile compared to AYTU. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs AGRX Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, MNK is priced at $0.34, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas AGRX's P/E ratio is -0.89. In terms of profitability, MNK's ROE is +1.26%, compared to AGRX's ROE of +0.93%. Regarding short-term risk, MNK is more volatile compared to AGRX. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs TLPH Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, TLPH has a market cap of 10M. Regarding current trading prices, MNK is priced at $0.34, while TLPH trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas TLPH's P/E ratio is -1.11. In terms of profitability, MNK's ROE is +1.26%, compared to TLPH's ROE of -1.29%. Regarding short-term risk, MNK is more volatile compared to TLPH. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs YCBD Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, YCBD has a market cap of 8.9M. Regarding current trading prices, MNK is priced at $0.34, while YCBD trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas YCBD's P/E ratio is 0.01. In terms of profitability, MNK's ROE is +1.26%, compared to YCBD's ROE of -8.81%. Regarding short-term risk, MNK is more volatile compared to YCBD. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs NLTX Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, MNK is priced at $0.34, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas NLTX's P/E ratio is -0.28. In terms of profitability, MNK's ROE is +1.26%, compared to NLTX's ROE of -0.49%. Regarding short-term risk, MNK is more volatile compared to NLTX. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs LCI Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, MNK is priced at $0.34, while LCI trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas LCI's P/E ratio is -0.04. In terms of profitability, MNK's ROE is +1.26%, compared to LCI's ROE of +1.66%. Regarding short-term risk, MNK is more volatile compared to LCI. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.
MNK vs BGXX Comparison
MNK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MNK stands at 4.5M. In comparison, BGXX has a market cap of 7.3M. Regarding current trading prices, MNK is priced at $0.34, while BGXX trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MNK currently has a P/E ratio of -0.44, whereas BGXX's P/E ratio is -0.76. In terms of profitability, MNK's ROE is +1.26%, compared to BGXX's ROE of -0.88%. Regarding short-term risk, MNK is more volatile compared to BGXX. This indicates potentially higher risk in terms of short-term price fluctuations for MNK.